Home › Funds › PERCEPTIVE ADVISORS LLC › ELVN
PERCEPTIVE ADVISORS LLC position in ELVN
ENLIVEN THERAPEUTICS INC · Health Care
PERCEPTIVE ADVISORS LLC reported holding 462,506 shares of ELVN (ENLIVEN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$21.2M, representing 0.41% of its reported portfolio and ranking #42 among its reported holdings. PERCEPTIVE ADVISORS LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's ELVN position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in ELVN in Q3 2026 at 462,506 shares (US$21.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 462.51K | $21.20M | New |
About ELVN and 13F data
ELVN (ENLIVEN THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in ELVN — the largest reported positions include ORBIMED ADVISORS LLC (US$310.6M), Polar Capital Holdings Plc (US$294.5M), Commodore Capital LP (US$150.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELVN
- ORBIMED ADVISORS LLC 6.78M sh · $310.64M · Q3 2026
- Polar Capital Holdings Plc 6.43M sh · $294.53M · Q3 2026
- Commodore Capital LP 3.27M sh · $150.13M · Q3 2026
- Vestal Point Capital, LP 3.23M sh · $147.83M · Q3 2026
- Fairmount Funds Management LLC 1.86M sh · $85.06M · Q3 2026
- Siren, L.L.C. 1.48M sh · $67.62M · Q3 2026
- Bellevue Group AG 1.47M sh · $67.34M · Q3 2026
- Logos Global Management LP 1.08M sh · $49.51M · Q3 2026
- First Light Asset Management, LLC 1.02M sh · $46.68M · Q3 2026
- Novo Holdings A/S 1.00M sh · $45.84M · Q3 2026
- First Turn Management, LLC 958.70K sh · $43.95M · Q3 2026
- SAMLYN CAPITAL, LLC 936.17K sh · $42.91M · Q3 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held ELVN?
PERCEPTIVE ADVISORS LLC has disclosed ELVN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is PERCEPTIVE ADVISORS LLC's current position in ELVN?
As of Q3 2026, PERCEPTIVE ADVISORS LLC holds 462.51K shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $21.20M, representing 0.41% of its reported portfolio and ranking #42.
Has PERCEPTIVE ADVISORS LLC been buying or selling ELVN?
In the latest 13F filing (Q3 2026), PERCEPTIVE ADVISORS LLC newly opened its position in ELVN.
Which other funds hold ELVN?
Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Commodore Capital LP, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.